Nkarta (NKTX) Research & Development (2019 - 2026)

Nkarta's quarterly Research & Development came in at $25.0 million in Q1 2026, up 3.38% year-on-year from $24.2 million in Q1 2025, and down 1.16% quarter-over-quarter from $25.3 million in Q4 2025.

Nkarta has reported Research & Development for 8 years, with the latest figure at $25.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Research & Development rose 3.38% year-over-year to $25.0 million; the trailing twelve-month figure through Mar 2026 stood at $91.2 million (down 4.63% YoY), and the FY2025 full-year result was $90.4 million, down 6.53% from the prior year.
  • Research & Development for Q1 2026 stood at $25.0 million, down from $25.3 million in the prior quarter.
  • The five-year high for Research & Development was $26.8 million in Q4 2022, with the low at $19.6 million in Q1 2022.
  • Average Research & Development over 5 years is $23.5 million, with a median of $23.4 million recorded in 2022.
  • Year-over-year, Research & Development surged 55.16% in 2022 and declined 20.01% in 2025.
  • Tracing NKTX's Research & Development over 5 years: stood at $26.8 million in 2022, then fell by 13.12% to $23.3 million in 2023, then declined by 0.84% to $23.1 million in 2024, then grew by 9.31% to $25.3 million in 2025, then declined by 1.16% to $25.0 million in 2026.
  • The last three Research & Development figures came in at $25.0 million (Q1 2026), $25.3 million (Q4 2025), and $20.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 626,092.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 4.32 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -101.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 1.46 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 961.60 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -2.30 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.54 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 364.87 Mn
10 Nkarta 232.80 Mn 232.80 Mn - 24.99 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 24.99 Mn
Dec 31, 2025 25.28 Mn
Sep 30, 2025 20.20 Mn
Jun 30, 2025 20.78 Mn
Mar 31, 2025 24.17 Mn
Dec 31, 2024 23.13 Mn
Sep 30, 2024 25.25 Mn
Jun 30, 2024 23.13 Mn
Mar 31, 2024 25.24 Mn
Dec 31, 2023 23.32 Mn
Sep 30, 2023 22.19 Mn
Jun 30, 2023 25.12 Mn
Mar 31, 2023 26.14 Mn
Dec 31, 2022 26.84 Mn
Sep 30, 2022 23.44 Mn
Jun 30, 2022 21.05 Mn
Mar 31, 2022 19.57 Mn
Dec 31, 2021 17.30 Mn
Sep 30, 2021 16.62 Mn
Jun 30, 2021 15.96 Mn
Mar 31, 2021 13.54 Mn
Dec 31, 2020 11.27 Mn
Sep 30, 2020 9.83 Mn
Jun 30, 2020 7.86 Mn
Mar 31, 2020 7.26 Mn
Dec 31, 2019 6.68 Mn
Sep 30, 2019 4.62 Mn
Jun 30, 2019 3.62 Mn